Sierra Leone

Mattia Panciroli / Flickr cc

CLICK HERE - WHO - First meeting of the Review Committee on the role of International Health Regulations in the Ebola response and WHO’s work in emergencies

cidrap.umn.edu - by Lisa Schnirring - August 25, 2015

A World Health Organization (WHO) committee tasked with reviewing how well the International Health Regulations (IHRs) worked during the Ebola outbreak wrapped up their first meeting today, with plans to dig into three main topics in the months ahead.

The group's newly elected chairman, Didier Houssin, MD, addressed reporters today during a telebriefing at the end of the 2-day meeting in Geneva. He is a surgeon who now heads the Evaluation Agency for Research and Higher Education in Paris. Houssin has served on WHO advisory groups before and has led some of its pandemic preparedness and IHR review groups in recent years.

(READ COMPLETE ARTICLE)

EUREKEALERT                                                                                                               Aug. 25, 2015
PITTSBURGH--The historic outbreak of Ebola virus disease in West Africa that began in March 2014 and has killed more than 11,000 people since, has raised new questions about the resilience of the virus and tested scientists' understanding of how to contain it. The latest discovery by a group of microbial risk-assessment and virology researchers suggests that the procedures for disposal of Ebola-contaminated liquid waste might underestimate the virus' ability to survive in wastewater.

Current epidemic response procedures from both the World Health Organization and the Centers for Disease Control and Prevention advise that after a period of days, Ebola-contaminated liquid can be disposed of directly into a sewage system without additional treatment.

However, new data recently published by researchers from the University of Pittsburgh, Drexel University, and the National Institutes of Health indicate that Ebola can survive in detectable concentrations in wastewater for at least a week or longer.

Read complete story.
http://www.eurekalert.org/pub_releases/2015-08/uop-pda082515.php

ASSOCIATED PRESS by CLARENCE ROY-MACAULAY    Aug. 24, 2015

MATENEH, Sierra Leone  — Health authorities in Sierra Leone released the country's last known Ebola patient from a hospital on Monday, a milestone that allows the nation to begin a 42-day countdown to being declared free of the virus that has killed nearly 4,000 people here.

Adama Sankoh, 40, centre, who contracted Ebola after her son died from the disease late last month stands with health officials the moment after she was discharge from Mateneh Ebola treatment center outskirt of Freetown, Sierra Leone, Monday, Aug. 24, 2015, Health authorities in Sierra Leone released the country's last known Ebola patient from the hospital on Monday, a milestone that allows the nation to begin a 42-day countdown to being declared free of the virus that has killed nearly 4,000 people here. (AP Photo/Alie Turay)

President Ernest Bai Koroma presented a certificate of discharge to Adama Sankoh, 40, who contracted Ebola after her son died from the disease late last month.

ASSOCIATED PRESS  by Carley Petesch              Aug. 23, 2015

DAKAR, Senegal --Lingering health problems afflicting many of the roughly 13,000 Ebola survivors have galvanized global and local health officials to find out how widespread the ailments are, and how to remedy them.

The World Health Organization calls it an emergency within an emergency. Many of the survivors have vision and hearing issues. Some others experience physical and emotional pains, fatigue and other problems. The medical community is negotiating uncharted waters as it tries to measure the scale of this problem that comes on the tail end of the biggest Ebola outbreak in history.

"If we can find out this kind of information, hopefully we can help other Ebola survivors in the future," Dr. Zan Yeong, an eye specialist involved in a study of health problems in survivors in Liberia, told The Associated Press.

About 7,500 people will enroll — 1,500 Ebola survivors and 6,000 of their close contacts — and will be monitored over a five-year period in the study launched by Partnership for Research on Ebola Vaccines in Liberia, or PREVAIL.

Read complete story.